Skip to main content

Table 2 Summary of biochemical and genetic investigations

From: Cerebrotendinous Xanthomatosis: diversity of presentation and refining treatment with chenodeoxycholic acid

 

serum cholestanol at diagnosis normal < 5 μmol/L

CSF cholestanol

reference range (0.252–0.376 μmol/L) based on healthy controls)

serum Cholestanol after treatment

Urine Bile acid alcohol

Genetic Confirmation

Patient 1

53

not done

7

High

Not done

Patient 2

145

1.06 μmol/L on standard dose, 0.49 μmol/L after CDCA dose increase

10

High

CYP27A1: c.1184 + 1G > A(;) 1263 + 1G > A, p.(?)(;)(?)

Patient 3

125

2.5 (μmol/L) before treatment

41

Not done

CYP27A1c.157del,p.(Arg53fs)

Patient 4

112

not done

not repeated as yet

Not done

CYP27A1: c.[1183 > T];[1183C > T], p[(Arg395Cys)];p[(Arg395Cys)]